MDM2 polymorphism and recurrence-free and overall survival in early stage non-small cell lung cancer (NSCLC)
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Harvard University, Massachusetts General Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2534645360
